CLVLY
Price
$8.14
Change
+$0.19 (+2.39%)
Updated
Jul 30 closing price
Capitalization
423.36M
CMXHF
Price
$174.00
Change
+$0.45 (+0.26%)
Updated
Jul 30 closing price
Capitalization
85.42B
Interact to see
Advertisement

CLVLY vs CMXHF

Header iconCLVLY vs CMXHF Comparison
Open Charts CLVLY vs CMXHFBanner chart's image
Clinuvel Pharmaceuticals
Price$8.14
Change+$0.19 (+2.39%)
Volume$2.18K
Capitalization423.36M
CSL
Price$174.00
Change+$0.45 (+0.26%)
Volume$81
Capitalization85.42B
CLVLY vs CMXHF Comparison Chart in %
Loading...
CLVLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMXHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLVLY vs. CMXHF commentary
Aug 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLVLY is a Buy and CMXHF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 01, 2025
Stock price -- (CLVLY: $8.26 vs. CMXHF: $173.00)
Brand notoriety: CLVLY and CMXHF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLVLY: 136% vs. CMXHF: 12%
Market capitalization -- CLVLY: $423.36M vs. CMXHF: $85.42B
CLVLY [@Biotechnology] is valued at $423.36M. CMXHF’s [@Biotechnology] market capitalization is $85.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $223.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLVLY’s FA Score shows that 1 FA rating(s) are green whileCMXHF’s FA Score has 1 green FA rating(s).

  • CLVLY’s FA Score: 1 green, 4 red.
  • CMXHF’s FA Score: 1 green, 4 red.
According to our system of comparison, CLVLY is a better buy in the long-term than CMXHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLVLY’s TA Score shows that 6 TA indicator(s) are bullish while CMXHF’s TA Score has 6 bullish TA indicator(s).

  • CLVLY’s TA Score: 6 bullish, 4 bearish.
  • CMXHF’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both CLVLY and CMXHF are a good buy in the short-term.

Price Growth

CLVLY (@Biotechnology) experienced а +8.12% price change this week, while CMXHF (@Biotechnology) price change was -2.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.13%. For the same industry, the average monthly price growth was +16.53%, and the average quarterly price growth was +40.85%.

Reported Earning Dates

CLVLY is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-1.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CMXHF($85.4B) has a higher market cap than CLVLY($423M). CMXHF has higher P/E ratio than CLVLY: CMXHF (31.74) vs CLVLY (16.55). CLVLY YTD gains are higher at: 7.208 vs. CMXHF (4.298). CMXHF has higher annual earnings (EBITDA): 4.73B vs. CLVLY (63.4M). CMXHF has higher revenues than CLVLY: CMXHF (14.7B) vs CLVLY (91.6M).
CLVLYCMXHFCLVLY / CMXHF
Capitalization423M85.4B0%
EBITDA63.4M4.73B1%
Gain YTD7.2084.298168%
P/E Ratio16.5531.7452%
Revenue91.6M14.7B1%
Total CashN/A1.52B-
Total DebtN/A12B-
FUNDAMENTALS RATINGS
CLVLY vs CMXHF: Fundamental Ratings
CLVLY
CMXHF
OUTLOOK RATING
1..100
912
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
2
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
4553
PRICE GROWTH RATING
1..100
4949
P/E GROWTH RATING
1..100
9075
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CMXHF's Valuation (2) in the null industry is in the same range as CLVLY (4). This means that CMXHF’s stock grew similarly to CLVLY’s over the last 12 months.

CMXHF's Profit vs Risk Rating (100) in the null industry is in the same range as CLVLY (100). This means that CMXHF’s stock grew similarly to CLVLY’s over the last 12 months.

CLVLY's SMR Rating (45) in the null industry is in the same range as CMXHF (53). This means that CLVLY’s stock grew similarly to CMXHF’s over the last 12 months.

CLVLY's Price Growth Rating (49) in the null industry is in the same range as CMXHF (49). This means that CLVLY’s stock grew similarly to CMXHF’s over the last 12 months.

CMXHF's P/E Growth Rating (75) in the null industry is in the same range as CLVLY (90). This means that CMXHF’s stock grew similarly to CLVLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLVLYCMXHF
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
54%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
54%
Momentum
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
62%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
53%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
55%
Advances
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
48%
Declines
ODDS (%)
Bearish Trend 8 days ago
76%
Bearish Trend 4 days ago
45%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
56%
Aroon
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
CLVLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMXHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WAMFX23.82N/A
N/A
Boston Trust Walden Midcap
SEVIX14.66N/A
N/A
SEI US Managed Volatility I (SIMT)
ATEYX167.87N/A
N/A
AB Sustainable Global Thematic Advisor
JEPAX14.06N/A
N/A
JPMorgan Equity Premium Income A
EEIFX9.82N/A
N/A
Monteagle Enhanced Equity Income Instl

CLVLY and

Correlation & Price change

A.I.dvisor tells us that CLVLY and ADAP have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLVLY and ADAP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLVLY
1D Price
Change %
CLVLY100%
+1.41%
ADAP - CLVLY
22%
Poorly correlated
-19.68%
QLGN - CLVLY
21%
Poorly correlated
-11.33%
ATNM - CLVLY
20%
Poorly correlated
+3.82%
BSEM - CLVLY
11%
Poorly correlated
+3.82%
CMXHF - CLVLY
10%
Poorly correlated
-0.57%
More

CMXHF and

Correlation & Price change

A.I.dvisor tells us that CMXHF and ACRV have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CMXHF and ACRV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMXHF
1D Price
Change %
CMXHF100%
-0.57%
ACRV - CMXHF
26%
Poorly correlated
-3.12%
ADCT - CMXHF
21%
Poorly correlated
-4.15%
IDRSF - CMXHF
21%
Poorly correlated
N/A
ARVN - CMXHF
20%
Poorly correlated
-1.78%
DSGN - CMXHF
20%
Poorly correlated
-3.23%
More